"Bisantrene was found to kill breast cancer cells from all common breast cancer subtypes including triple negative, ER+, and Her2+"
What a superb announcement. Now we as shareholders rejoyce, just think about the good that this company is likely to do.
Ann: Compelling Preclinical Breast Cancer Results, page-160
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.125(8.68%) |
Mkt cap ! $259.8M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.57 | $1.46 | $206.0K | 136.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4751 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 2500 | 1 |
View Market Depth
| Last trade - 14.47pm 12/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |